The present study aims to evaluate whether the use of a "dual trigger" can improve IVF outcomes, compared to GnRH agonist (GnRH-a) alone, in patients at high risk of OHSS undergoing a freeze-all cycle. By examining freeze-all cycles with frozen embryo transfer(s) (FET) only, we eliminate the potential confounding issue of inadequate luteal support to the endometrium and focus primarily on the effect of a "dual trigger" on oocyte quality and embryo potential. To our best knowledge, there have been no randomized, controlled trials conducted to address this hypothesis.
1 Primary · 11 Secondary · Reporting Duration: 2-3 days after oocyte retrieval
88 Total Participants · 2 Treatment Groups
Primary Treatment: Treatment Arm- Group A · Has Placebo Group · Phase 4
Age 18 - 40 · Female Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: